Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Current Deferred Revenue (2022 - 2025)

Historic Current Deferred Revenue for Immunocore Holdings (IMCR) over the last 2 years, with Q3 2025 value amounting to $582000.0.

  • Immunocore Holdings' Current Deferred Revenue changed N/A to $582000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $582000.0, marking a year-over-year change of. This contributed to the annual value of $7.8 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Immunocore Holdings reported Current Deferred Revenue of $582000.0 as of Q3 2025.
  • In the past 5 years, Immunocore Holdings' Current Deferred Revenue registered a high of $7.8 million during Q4 2022, and its lowest value of $582000.0 during Q3 2025.